Portside Wealth Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.61M Buy
8,365
+312
+4% +$50.7K 0.18% 130
2026
Q2
$1.1M Buy
8,053
+2,490
+45% +$306K 0.13% 172
2026
Q1
$655K Sell
5,563
-150
-3% -$21K 0.09% 217
2025
Q4
$936K Buy
5,713
+3,511
+159% +$550K 0.13% 178
2025
Q3
$294K Buy
+2,202
New +$267K 0.04% 377

Other funds holding RGEN

Portside Wealth Group's RGEN Position: Q3 2026 in Review

Portside Wealth Group increased its Repligen (RGEN) stake by 3.9% in Q3 2026, buying an estimated $50.7K and bringing the position to 8,365 shares worth $1.61M. The position accounts for 0.18% of the portfolio, ranked #130.

Portside Wealth Group first reported a position in RGEN in Q3 2025 and has held it in 5 quarters since. 85 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Portside Wealth Group held 8,365 shares of Repligen worth $1.61M as of Q3 2026.
  • Portside Wealth Group bought 312 Repligen shares in Q3 2026, an estimated $50.7K.
  • Repligen made up 0.18% of Portside Wealth Group's portfolio in Q3 2026, its #130 holding.
  • Portside Wealth Group first reported a position in Repligen in Q3 2025 and has held it in 5 quarters since.
  • 85 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Portside Wealth Group's 13F filing for Q3 2026, filed 20 Oct 2026.